Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ftan
    Junior Member
    • May 2012
    • 1

    #1

    Cuff gene and transcript IDs

    I'm new to RNA seq and I hope someone can give me some general insight into my cuffcompare output.

    My Question: Why are there are multiple cuff_gene_id and cuff_id per reference transcript? I'm trying to extract a single FPKM value per reference transcript, so I don't know how to treat multiple entries for a single gene. For example, my cuffcompare output contains multiple lines for Map4k4:

    Map4k4 Map4k4 c CUFF.155 CUFF.155.1 100 569.106817 284.553408 853.660225 378.272059 91 CUFF.155.1 5782
    Map4k4 Map4k4 c CUFF.156 CUFF.156.1 100 373909.473540 166501.815197 581317.131882 248528.926936 38 CUFF.156.1 5782
    Map4k4 Map4k4 i CUFF.157 CUFF.157.1 100 870264.340261 319860.843931 1420667.836591 578444.457660 37 CUFF.157.1 5782
    Map4k4 Map4k4 i CUFF.158 CUFF.158.1 100 870264.340261 319860.843931 1420667.836591 578444.457660 37 CUFF.158.1 5782

    Are these individual fragments that have been mapped to Map4k4 with an associated FPKM? If so, is the FPKM for Map4k4 just the sum of individual entries? Sorry, I'm new...

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...